Close Menu

BioInquire

Simultaneous qual-quan workflows generate significantly more data than many conventional mass spec assays, posing a challenge for vendors of ensuring that their software offerings keep pace with the expanded capabilities of their hardware.

The separations products company plans to buy the mass spec analysis software maker for at least $3 million.

The deal, valued at more than $3 million, would provide NuSep with BioInquire's ProteoIQ software, which helps customers identify proteins separated by mass spec instruments.

The firm will use the funding to develop its proteomics software platform.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.